BlackRock, Inc. 13D and 13G filings for scPharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-05 12:21 pm Sale |
2024-03-31 | 13G | scPharmaceuticals Inc. SCPH |
BlackRock Inc. BLK |
1,801,610 4.990% |
-61,829 (-3.32%) |
Filing |
| 2024-02-02 3:57 pm Purchase |
2023-12-31 | 13G | scPharmaceuticals Inc. SCPH |
BlackRock Inc. BLK |
1,863,439 5.200% |
1,863,439 (New Position) |
Filing |